Eli Lilly Expands Cancer Treatment Pipeline with $2.5 Billion Scorpion Therapeutics Deal
Eli Lilly and Company, a global leader in pharmaceutical innovation, announced its intent to acquire Scorpion Therapeutics’ experimental cancer therapy, ...
© 2025 ImpactWealth | Disclaimer – Privacy Policy